Takebayashi Katsushi, Sonoda Hiromichi, Shimizu Tomoharu, Ohta Hiroyuki, Minamiguchi Hitoshi, Ishida Mitsuaki, Mekata Eiji, Endo Yoshihiro, Tani Tohru, Tani Masaji
Department of Surgery, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu, Shiga, 520-2192, Japan.
Department of Hematology, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu, Shiga, 520-2192, Japan.
World J Surg Oncol. 2016 Apr 19;14:116. doi: 10.1186/s12957-016-0873-x.
Pyomyositis is a rare, subacute, deep pyogenic infection of the muscle tissue. This disease has been previously described in patients that were immunocompromised due to a hematological malignancy.
A 68-year-old man with a history of chronic myeloid leukemia was treated with imatinib. He was diagnosed with ascending colon cancer and underwent curative surgery. His postoperative course was uneventful, and he was healthy at 6 months after surgery, allowing for reinitiation of imatinib therapy. After the reinitiation of therapy, a computed tomography (CT) scan revealed a mass shadow in the right iliopsoas muscle. This lesion was clinically diagnosed as recurrent colon cancer with an abscess, which was resected surgically. A pathological examination uncovered both edema and inflammation. Two months after the second surgery, imatinib therapy was reinitiated; however, he again developed painful swelling and erythema in his right thigh. A CT scan revealed a similar shadow as described previously. He was then diagnosed with pyomyositis; he underwent incisional drainage and was administered linezolid. Following the treatment for pyomyositis, there was no cancer recurrence or evidence of any recurrent pyomyositis.
Findings from this case suggest that both undergoing surgery and receiving imatinib therapy may modulate an individual's immune response, whereby the surgical site becomes more prone to infection and may predispose an individual to pyomyositis. The case report is followed by a discussion of the literature regarding this disease, including potential risk factors and the underlying pathogenesis.
脓性肌炎是一种罕见的、亚急性的肌肉组织深部化脓性感染。此前曾在因血液系统恶性肿瘤而免疫功能低下的患者中描述过这种疾病。
一名68岁有慢性髓性白血病病史的男性接受了伊马替尼治疗。他被诊断为升结肠癌并接受了根治性手术。术后过程顺利,术后6个月时他身体健康,得以重新开始伊马替尼治疗。重新开始治疗后,计算机断层扫描(CT)显示右髂腰肌有肿块阴影。该病变临床诊断为复发性结肠癌伴脓肿,遂进行手术切除。病理检查发现既有水肿又有炎症。第二次手术后两个月,重新开始伊马替尼治疗;然而,他右大腿再次出现疼痛性肿胀和红斑。CT扫描显示出与之前描述的类似阴影。随后他被诊断为脓性肌炎;他接受了切开引流并使用了利奈唑胺。经过脓性肌炎治疗后,未出现癌症复发,也没有任何脓性肌炎复发的迹象。
该病例的研究结果表明,接受手术和伊马替尼治疗都可能调节个体的免疫反应,从而使手术部位更容易发生感染,并可能使个体易患脓性肌炎。病例报告之后是对有关该疾病的文献的讨论,包括潜在危险因素和潜在发病机制。